探索细菌衍生的EVs在向酶替代疗法的潜力:机制,应用和未来方向
Mohanakrishna Raja1, Karthikeyan Ramamurthy1, Gokul Sudhakaran2
1Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulatur, Chengalpattu District, 603203, Tamil Nadu, India.
Archives of microbiology
|April 10, 2025
概括
益生菌衍生的细胞外囊泡 (EVs) 在溶解体储存疾病 (LSDs) 中显示出酶替代疗法 (ERT) 的前景. 这些纳米载体可以穿越血脑屏障,调节免疫反应,提供一种新的治疗策略.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 细胞生物学 细胞生物学
背景情况:
- 细胞外囊泡 (EVs) 对于细胞间通信至关重要,运输DNA,RNA和蛋白质等生物分子.
- 益生菌衍生的EV具有潜力作为纳米载体用于治疗,特别是酶替代疗法 (ERT).
- 目前用于溶酶体储存疾病 (LSD) 的ERT面临的挑战包括血脑屏障 (BBB) 透和酶降解.
研究的目的:
- 审查益生菌衍生的EVs在溶酶储存疾病 (LSDs) 的酶替代疗法 (ERT) 中的治疗潜力.
- 探索益生菌EV相对于传统ERT方法和活益生菌细菌的优势.
- 突出益生菌EVs的免疫调节特性和有针对性的传递能力.
主要方法:
- 文献综述,重点关注益生菌衍生的EV在ERT和炎症条件中的应用.
- 分析电动汽车货物运输机制,包括穿越血脑屏障 (BBB).
- 评估免疫调节效应,并与现有的治疗策略进行比较.
主要成果:
- 益生菌EV可以有效地在BBB中传递酶货物,准受LSD影响的组织.
- 电动汽车具有固有的免疫调节特性,对炎症性疾病有益.
- 益生菌电动车在传统ERT上具有优势,因为它可以最大限度地减少目标外传输和降解.
结论:
- 益生菌EVs代表了一个有前途的新策略,用于在LSD中向酶递送和调节炎症疾病中的免疫反应.
- 需要进一步的研究来优化EV生产,开发向疗法,并通过临床试验证实安全性和疗效.
- 探索各种益生菌菌株可以扩大益生菌EVs的治疗应用和多功能性.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:26Transformation
Microbial communities are dynamic environments where cell lysis releases free DNA into the surroundings. Other cells can take up this extracellular DNA through a process known as transformation.When a cell incorporates this foreign DNA into its genome, resulting in genetic modification, the process is known as transformation. Cells capable of this process are termed competent. Competence can be natural, as observed in certain bacteria and archaea, or artificially induced in the...
01:24Evolution of New Traits in Microbes
Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...